Forth nightly review: hereditary ovarian carcinoma.
作者信息
Kasprzak L, Foulkes W D, Shelling A N
机构信息
Division of Medical Genetics, Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 1A4.
出版信息
BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786.
Abstract
摘要
相似文献
1
Forth nightly review: hereditary ovarian carcinoma.
BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786.
2
High frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jewish ovarian cancer patients.
Gynecol Oncol. 1998 Jul;70(1):152. doi: 10.1006/gyno.1998.5007.
3
Breast & ovarian cancer. Issues in risk assessment.
Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4.
4
Hereditary breast cancer.
Pol J Pathol. 1998;49(2):59-66.
5
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861.
6
Complex decision-making for BRCA1/2 carriers.
Cancer J Sci Am. 1999 Sep-Oct;5(5):266-8.
7
Preventive gynecologic surgery for BRCA1/2 carriers--information for decision-making.
Gynecol Oncol. 2001 Oct;83(1):168-70. doi: 10.1006/gyno.2001.6381.
8
Chemoprevention of hereditary ovarian cancer.
N Engl J Med. 1998 Aug 13;339(7):469-71. doi: 10.1056/NEJM199808133390710.
9
Oral contraceptives and hereditary ovarian cancer.
N Engl J Med. 1999 Jan 7;340(1):59; author reply 60. doi: 10.1056/NEJM199901073400113.
10
Differences between hereditary and sporadic ovarian cancer.
Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):151-3. doi: 10.1016/s0301-2115(98)00218-8.
引用本文的文献
1
Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.
Abdom Radiol (NY). 2021 Jun;46(6):2281-2292. doi: 10.1007/s00261-020-02911-x. Epub 2021 Apr 13.
2
Ovarian cancer mortality among women aged 40-79 years in relation to reproductive factors and body mass index: latest evidence from the Japan Collaborative Cohort study.
J Gynecol Oncol. 2013 Jul;24(3):249-57. doi: 10.3802/jgo.2013.24.3.249. Epub 2013 Jul 4.
3
Molecular genetics of ovarian cancer.
Mol Biotechnol. 2001 Sep;19(1):13-28. doi: 10.1385/MB:19:1:013.
4
What we could do now: molecular pathology of gynaecological cancer.
Mol Pathol. 2001 Aug;54(4):222-4. doi: 10.1136/mp.54.4.222.
本文引用的文献
1
2
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099.
3
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.
Am J Obstet Gynecol. 1998 Aug;179(2):403-10. doi: 10.1016/s0002-9378(98)70372-2.
4
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
N Engl J Med. 1998 Aug 13;339(7):424-8. doi: 10.1056/NEJM199808133390702.
5
A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.
Br J Cancer. 1998 Apr;77(8):1199-202. doi: 10.1038/bjc.1998.202.
6
Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
Clin Cancer Res. 1998 Jan;4(1):235-40.
7
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
Am J Hum Genet. 1998 Mar;62(3):676-89. doi: 10.1086/301749.
8
Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.
J Clin Oncol. 1998 Feb;16(2):397-404. doi: 10.1200/JCO.1998.16.2.397.
9
Is hereditary site-specific ovarian cancer a distinct genetic condition?
Am J Med Genet. 1998 Jan 6;75(1):55-8. doi: 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r.
10
BRCA2 mutations in hereditary breast and ovarian cancer in France.
Am J Hum Genet. 1997 May;60(5):1236-9.
Zotero 插件